Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.4B | 11.4B | 10.6B | 10.5B |
| Cost of revenue | 6.1B | 6.6B | 6.3B | 6.2B |
| Gross profit | 4.2B | 4.8B | 4.3B | 4.3B |
| Operating expense | ||||
| Research & development | 342M | 374M | 346M | 339M |
| Selling general and admin | 2.1B | 2.2B | 2.1B | 2.1B |
| Other operating expenses | — | — | — | — |
| Operating income | 1.8B | 2.2B | 1.9B | 1.9B |
| Non operating interest income | ||||
| Income | 203M | 227M | 277M | 295M |
| Expense | 303M | 317M | 356M | 354M |
| Other income expense | -95M | -214M | -61M | -72M |
| Pretax income | 1.6B | 1.9B | 1.7B | 1.8B |
| Tax provision | 95M | 150M | 99M | 128M |
| Net income | 1.5B | 1.8B | 1.6B | 1.6B |
| Basic EPS | 4.0 | 4.8 | 4.3 | 4.1 |
| Diluted EPS | 4.0 | 4.8 | 4.3 | 4.0 |
| Basic average shares | 378M | 382M | 382M | 382M |
| Diluted average shares | 379M | 383M | 384M | 383M |
| EBITDA | 2.7B | 3.2B | 2.9B | 3.0B |
| Net income from continuing op. | 1.5B | 1.8B | 1.6B | 1.6B |
| Minority interests | -4M | 6M | 0 | -6M |
| Preferred stock dividends | — | — | — | — |